Direct-to-Consumer Genetic Testing Market Report Size, Share, By Test Type, Technology Type, Service Provider, Application, Distribution Channel, and Region - Trends, Analysis, and Forecast till 2034

Report Code: PMI563924 | Publish Date: September 2024 | No. of Pages: 182

Direct To Consumer Genetic Testing Market Overview

  • The direct-to-consumer genetic testing market size to be USD 20.7 Billion by 2034.
  • The market was Worth USD 2.8 Billion in 2024.
  • The market is expanding at a CAGR of 24.5% during the forecast period.

Direct-to-consumer genetic Testing refers to genetic tests that are marketed directly to consumers without the need for a healthcare provider or medical intermediary. Consumers can order these tests online or over the counter collect a sample (usually saliva or a cheek swab), and send it to a laboratory for analysis. These tests provide insights into a wide range of genetic factors, including ancestry, health risks and carrier status for genetic conditions, personal traits, wellness, and even pharmacogenomics how individuals may respond to certain medications. Rising demand for personalized healthcare to boost direct-to-consumer genetic testing market during the forecast period.

Key Takeaways:

  • North America is expected to lead the market due to the presence of advanced healthcare infrastructure and high disposable incomes.
  • Asia Pacific is projected to experience the rapid growth in the market during the forecast period. The region’s expansion is attributed to the rising health awareness and technological advancements in the region.

Direct-to-Consumer Genetic Testing Market Share

                             To Know More, Request Free Sample Report

Direct To Consumer Genetic Testing Market Drivers & Restraints

Increasing Consumer Awareness and Demand for Personalized Healthcare Drive Market Growth

  • More customers are looking for information about their history, genetic predispositions for diseases, and personalized treatment as they become more aware of genetics and its impact on health.
  • Preventive health practices are becoming more and more popular, and genetic testing provides useful information for individualized health management, including diet and exercise regimens.
  • For instance, in March 2023, 23andMe, Inc. expanded its health-focused offerings providing consumers with insights into disease risks and carrier status, reflecting the growing demand for personalized genetic health data. 

Market’s Expansion is Propelled by the Advancements in Genetic Testing Technologies

  • The reduction in the cost of genetic sequencing has allowed DTC companies to offer comprehensive reports at lower prices, expanding access to a broader audience. Advances in whole-genome sequencing and artificial intelligence-driven analysis have improved the depth and accuracy of test results.
  • For instance, in April 2023, Companies, such as Veritas Genetics are now offering whole-genome sequencing for consumers, marking a shift towards more comprehensive and affordable genetic testing.

Rising Consumer Interest in Ancestry and Heritage Testing to Boost Market Expansion

  • The curiosity to discover family origins, ancestral heritage, and ethnicity has driven significant growth in the DTC-GT market, especially for companies offering ancestry-focused tests. Popularity has surged as these tests connect people to distant relatives and provide insights into genetic backgrounds, further encouraged by marketing campaigns and social media sharing.
  • For instance, in June 2023, Ancestry.com introduced new regional breakdowns of genetic heritage in previously unexplored regions leading to a surge in test kit purchases and enhancing user experience.

Restraints:

Market May Grow Less Owing to the Privacy and Data Security Concerns

  • Consumers are increasingly wary about how their sensitive genetic data is stored, shared, and used by third-party entities, including concerns about potential data breaches. Concern concerning data being shared with insurance companies, pharmaceutical corporations, or law enforcement organizations for uses other than testing is on the rise.

Lack of Medical Supervision and Interpretation to Hamper Market Growth

  • Consumers may misinterpret their genetic data without expert medical advice, which could cause needless worry or lead to poor health decisions. Additionally, there is worry that over-the-counter testing could result in false positives or negatives, which could be upsetting psychologically or lead to unsuitable medical interventions.

Opportunities:

Growth into Specialty Genetic Testing Industries Can Provide Better Future Growth Opportunities

  • Consumers are increasingly interested in personalized lifestyle recommendations, such as tailored diets or skincare routines based on their genetic makeup. These relatively unexplored niche markets offer the potential for expansion by meeting certain demands related to health and fitness.

Partnerships with Healthcare Providers and Insurance Companies Can Drive Market Growth in Future

  • Collaborating with healthcare providers and insurance companies can open new revenue streams and enhance the credibility of DTC genetic tests. These collaborations may make it possible to use the results of genetic testing in official healthcare settings, which would support individualized treatment regimens and preventative care.

Direct To Consumer Genetic Testing Market Segmentations & Regional Insights

The direct-to-consumer genetic testing market is segmented into test type, technology type, service provider, application, distribution channel, and region

Test Type Insights:

On the basis of test type, the market is segmented into nutrigenomics testing, carrier testing, wellness & fitness testing, predictive testing, and others. The nutrigenomics testing segment is expected to dominate the market during the forecast period as it helps in analyzing an individual’s genetic information to deliver personalized dietary recommendations.

Technology Type Insights:

By technology type, the market is classified into whole genome sequencing (WGS), exome sequencing, next-generation sequencing (NGS), and others. The whole genome sequencing (WGS) holds the largest direct-to-consumer genetic testing market as it offers insights into genetic predispositions to a large range of traits and diseases.

Service Provider Insights:

Based on service provider, the market is divided into in-house laboratories, third-party providers, and pharmaceutical partnerships. The leading segment in the market is the in-house laboratories as it allow companies to maintain control over data security, quality, and testing accuracy.

Application Insights:

Under application, the market is categorized into personalized medicine, clinical diagnostics, research applications, and consumer insights. The clinical diagnostics segment is expected to witness high growth in the market due to its ability to identify genetic disorders, guide treatment options, and predict disease progression.

Distribution Channel Insights:

By distribution channel, the market is bifurcated into online platforms and offline platforms. The online platforms segment is expected to dominate the market during the projected period as they offer consumers a higher degree of privacy and anonymity to conduct testing without any face-to-face interactions.

Regional Insights:

Geographically, the market is studied across North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

  • North America: This region benefits from a relatively supportive regulatory framework for genetic testing though it is subject to scrutiny by agencies like the FDA. Advanced healthcare infrastructure and high disposable incomes drive demand for genetic testing services.
  • Asia Pacific: This region is experiencing rapid growth in genetic testing due to increasing health awareness and technological advancements. Investments in healthcare infrastructure and increasing disposable incomes are driving the growth of the target market.

Direct-to-Consumer Genetic Testing Market Report Scope:

Attribute

Details

Market Size 2024

USD 2.8 Billion

Projected Market Size 2034

USD 20.7 Billion

CAGR Growth Rate

24.5%

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 to 2034

Regional scope

North America - U.S. and Canada

Europe – U.K., Germany, Spain, France, Italy, Russia, and Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, and Rest of Asia Pacific

Latin America - Brazil, Mexico, Argentina, and Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segmentation:

By Test Type:

  • Nutrigenomics Testing
  • Carrier Testing
  • Wellness & Fitness Testing
  • Predictive Testing
  • Others

By Technology Type:

  • Whole Genome Sequencing (WGS)
  • Exome Sequencing
  • Next-Generation Sequencing (NGS)
  • Others

By Service Provider:

  • In-house Laboratories
  • Third-Party Providers
  • Pharmaceutical Partnerships

By Application:

  • Personalized Medicine
  • Clinical Diagnostics
  • Research Applications
  • Consumer Insights

By Distribution Channel:

  • Online Platforms
  • Offline Platforms

By Region:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Direct To Consumer Genetic Testing Market Competitive Landscape & Key Players

The key players operating the Direct-to-Consumer Genetic Testing Market include 23andMe, Inc., Ancestry.com LLC, MyHeritage Ltd., Living DNA Ltd., Helix OpCo LLC, Futura Genetics, Color Genomics, Inc., DNAfit, Counsyl, Inc., Veritas Genetics, MapMyGenome India Ltd., Orig3n, Inc., LetsGetChecked, Pathway Genomics Corporation, and EasyDNA.

List of Key Players in the Market:

  • 23andMe, Inc.
  • Ancestry.com LLC
  • MyHeritage Ltd.
  • Living DNA Ltd.
  • Helix OpCo LLC
  • Futura Genetics
  • Color Genomics, Inc.
  • DNAfit
  • Counsyl, Inc.
  • Veritas Genetics
  • MapMyGenome India Ltd.
  • Orig3n, Inc.
  • LetsGetChecked
  • Pathway Genomics Corporation
  • EasyDNA

Direct-to-Consumer Genetic Testing Market Players

                     To Access More Companies, Download Free Sample PDF

Direct To Consumer Genetic Testing Market Recent News

  • In June 2023, MyHeritage unveiled an upgraded ancestry test that now includes more detailed regional breakdowns, allowing users to trace their ancestry with greater specificity. This update comes in response to growing consumer interest in more granular genetic ancestry information.
  • In July 2023, in the wake of increasing demand for personalized healthcare services, 23andMe expanded its offerings by launching a new pharmacogenomics test, helping consumers understand how their genetics may affect their response to specific medications. This innovation underscores the shift from ancestry-focused tests toward health-oriented genetic services.
  • In July 2023, Quest Diagnostics, the leader in diagnostic information services, announced the launch of its first consumer-initiated genetic test, now exclusively available through the company's consumer health business at questhealth.com. Called Genetic Insights, the new offering helps people understand their potential risk of developing certain inheritable health conditions, with advanced technology and end-to-end support that includes personalized health reports and access to genetic counseling.

More Related Reports

Epigenetics Market
Genetic Testing Market
Food Safety Testing Market
Endocrine Testing Market
Antimicrobial Susceptibility Testing Market

Direct To Consumer Genetic Testing Market Company Profile

Company Name

Living DNA Ltd.

Headquarters

Somerset, England

CEO

Frome Nicholson

Employee Count (2024)

9-11 Employees

FAQs

Direct-to-Consumer Genetic Testing Market was valued at US$ 2.8 Billion in 2024 and is projected to grow at a CAGR of 24.5% to reach US$ 20.7 million by 2034

The Direct-to-Consumer Genetic Testing Market is segmented into Test Type, Technology Type, Service Provider, Application, and Distribution Channel and Region.

Factors driving the market include increasing consumer awareness and demand for personalized healthcare, advancements in genetic testing technologies, and increasing interest in ancestry and heritage testing.

The Direct-to-Consumer Genetic Testing Market's restraints include privacy and data security concerns, and lack of medical supervision and interpretation.

The Direct-to-Consumer Genetic Testing Market is segmented by region into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America is expected to dominate the Market.

The key players operating the Direct-to-Consumer Genetic Testing Market include 23andMe, Inc., Ancestry.com LLC, MyHeritage Ltd., Living DNA Ltd., Helix OpCo LLC, Futura Genetics, Color Genomics, Inc., DNAfit, Counsyl, Inc., Veritas Genetics, MapMyGenome India Ltd., Orig3n, Inc., LetsGetChecked, Pathway Genomics Corporation, and EasyDNA.